Potent and systematic RNAi mediated silencing with single oligonucleotide compounds |
| |
Authors: | Lapierre Jennifer Salomon William Cardia James Bulock Karen Lam Jessica T Stanney William J Ford Glenna Smith-Anzures Bernice Woolf Tod Kamens Joanne Khvorova Anastasia Samarsky Dmitry |
| |
Affiliation: | RXi Pharmaceuticals Corporation, Gateway Life Sciences Park, Worcester, Massachusetts 01605, USA. |
| |
Abstract: | RNA interference (RNAi) has been established as an important tool for functional genomics studies and has great promise as a therapeutic intervention for human diseases. In mammalian cells, RNAi is conventionally induced by 19-27-bp RNA duplexes generated by hybridization of two complementary oligonucleotide strands (oligos). Here we describe a novel class of RNAi molecules composed of a single 25-28-nucleotide (nt) oligo. The oligo has a 16-nt mRNA targeting region, followed by an additional 8-10 nt to enable self-dimerization into a partially complementary duplex. Analysis of numerous diverse structures demonstrates that molecules composed of two short helices separated by a loop can efficiently enter and activate the RNA-induced silencing complex (RISC). This finding enables the design of highly effective single-oligo compounds for any mRNA target. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|